TTD | Drug: D0G8LN

Drug General Information
Drug ID	D0G8LN
Former ID	DCL001202
Drug Name	ISIS-SGLT2
Drug Type	Antisense drug
Indication	Type 2 diabetes [ICD9: 250; ICD10:E11]		Phase 1	[551052]
Company	ISIS Pharm
Target and Pathway
Target(s)	mRNA of sodium-glucosetransporter-2	Target Info		[551052]
Reactome	Hexose transport
	Na+-dependent glucose transporters
	Inositol transporters
WikiPathways	NRF2 pathway
WikiPathways	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
References
Ref 551052	Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011).
Ref 551052	Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information